VeriMomIst ginsenoside rg4 in der Schwangerschaft sicher?
No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).
Related ingredients
Frequently asked questions
- Ist ginsenoside rg4 in der Schwangerschaft sicher?
- No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).
- Ist ginsenoside rg4 während des Stillens sicher?
- No evidence was found that Rg4 is classified for reproductive or lactation hazard, and no studies showing transfer into milk or lactation toxicity for Rg4 were identified. By the priority rules, absence of CIR/SCCS/harmonised flags and lack of Rg4‑specific lactation data leads to default low hazard and mechanism scores. (Sources: PubChem/supplier pages; literature search on PubMed; EWG ingredient summary).
- Ist ginsenoside rg4 sicher für Babyhaut?
- No infant‑specific toxicity data for Rg4 were identified. Dermal exposure assessment: Rg4 is a large, polar glycoside (MW ~767) typical of ginsenosides; such molecules have low dermal permeability, so adult topical exposure is likely negligible (e=0). However, given immature infant barrier and instruction in scoring, exposure for baby skin is increased by +1 to e=1 in absence of infant data. No infant dermal adverse effects or studies were found. (Sources: PubChem/supplier data on structure/MW; lack of reproductive/infant studies on PubMed; EWG ingredient page).
- Wie bewertet VeriMom ginsenoside rg4?
- VeriMom bewertet ginsenoside rg4 mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu ginsenoside rg4?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu ginsenoside rg4 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.